Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Savara revenue
Savara's revenue is $257,000.
What is Savara's revenue?
- Savara's revenue growth from 2015 to 2020 is 375.93%.
- Savara has 33 employees, and the revenue per employee ratio is $7,787.
- Savara's peak quarterly revenue was $399.9K in 2016(q4).
- Savara peak revenue was $400.0K in 2016.
- Savara annual revenue for 2016 was 400.0K, 640.74% growth from 2015.
- Savara annual revenue for 2020 was 257.0K, -35.75% growth from 2016.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Savara historical revenue
Savara's peak revenue was $400.0K in 2016. The peak quarterly revenue was $399.9K in 2016(q4).
Savara's revenue increased from $54.0k in 2015 to $257.0K currently. That's a 375.93% change in annual revenue.
Savara annual revenue
Savara annual revenue over time
| Fiscal year / year | Savara revenue |
|---|---|
| 2015 | $54,000 |
| 2016 | $400,000 |
| 2020 | $257,000 |
Savara quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Savara quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2015 | - | - | - | $54,037 |
| 2016 | - | - | - | $399,874 |
| 2020 | - | - | $256,000 | $1,000 |
Savara jobs nearby
Do you work at Savara?
Did Savara meet its revenue projections?
Savara financial information
| CEO | Matthew Pauls |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 33 |
| Date Founded | 2007 |
| Headquarters | Austin, Texas |
| Number of Locations | 1 |
| Revenue | $257,000 |
| Net Income | -$38,150,000 |
| EBITDA | ($103.0M) (2024) |
| Tax Rate | 0.0% |
| Total Assets | $139,777,000 |
| Ticker | SVRA |
Savara jobs you might like
Savara financing
Savara received early financing of $3.0M on 2012-07-27.
| Series | Round size | Date |
|---|---|---|
| Series B | $3M | 07/2012 |
| Series B | $14.3M | 06/2013 |
| Series C | $20M | 03/2016 |
| Debt Financing | $15M | 04/2017 |
| Post Ipo Equity | $47M | 10/2017 |
| Grant | $5M | 11/2017 |
| Post Ipo Equity | $26.8M | 01/2020 |
| Post Ipo Equity | $130M | 03/2021 |
| Post Ipo Debt | $26.5M | 04/2022 |
Savara investors
| Investors | Security type |
|---|---|
| Keiretsu Forum | Series B |
| Keiretsu Forum Northwest | Series B |
| Keiretsu Forum Mid Atlantic | Series B |
| Carthona Capital | Series C |
| Keiretsu Forum Northwest | Series C |
| Green Park & Golf Ventures | Series C |
| Keiretsu Capital | Series C |
| Haas Portman | Series C |
| Silicon Valley Bank | Debt Financing |
| Cystic Fibrosis Foundation | Grant |
| Bain Capital Life Sciences | Post Ipo Equity |
| Silicon Valley Bank | Post Ipo Debt |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Savara, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Savara. The employee data is based on information from people who have self-reported their past or current employments at Savara. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Savara. The data presented on this page does not represent the view of Savara and its employees or that of Zippia.
Savara may also be known as or be related to Aravas Inc., SAVARA INC, Savara, Savara Inc, Savara Inc. and Savara, Inc.